Stock Market Sectors Stock Market Holidays & Hours After Hours Trading Portfolio Management Cryptocurrency Dividend Investing Portfolio Strategy Fixed Income Retirement IPO's Podcasts Video Hub Editors' Picks Stock Analysis Stock Ideas Long Ideas Stock Upgrades & Downgrades Editors' Picks Quick Picks &...
手机东方财富网是东方财富网的手机门户网站,为亿万用户打造一个手机联通世界的超级平台,提供7*24小时全面及时的财经中文资讯,内容覆盖国内外突发事件、股市资讯、全球新闻、产业资讯、实用信息等。手机东方财富网触屏版 - eastmoney.com
Lake Street维持BioLife Solutions(BLFS.US)买入评级,维持目标价30美元 Lake Street分析师Thomas Flaten维持$BioLife Solutions(BLFS.US)$买入评级,维持目标价30美元。根据TipRanks数据显示,该分析师近一年总胜率为31.8%,总平均回报率为-3.8%。提示: TipRanks为独立第三方,提供金融分析师的分析数据,并计算分析师推荐...
BLFS | Complete BioLife Solutions Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
百度股市通提供BioLife Solutions, Inc.(BLFS)的行情报价、新闻资讯、股评、财报等信息,让用户在复杂的金融市场,更简单的获取投资信息。
公司名称BioLife Solutions 上市日期2014/03/26 成立日期1987 CEOMr. Roderick De Greef 所属市场纳斯达克 员工数量414 年结日12-31 公司地址3303 Monte Villa Parkway,Suite 310 城市Bothell 省份华盛顿州 国家美国 邮编98021 电话1-425-402-1400 网址http://www.biolifesolutions.com 董事高管 姓名 职务 年薪 Ro...
Keybanc:维持BioLife Solns(BLFS.US)评级,由增持调整至增持评级, 目标价由30.00美元调整至33.00美元。 BioLife Solutions(BLFS.US)公司简介:BioLife Solutions Inc 活跃于医疗保健领域。该公司致力于开发、制造和销售用于细胞、组织和器官的生物保护工具和服务,包括临床级细胞和组织低温储存和冷冻保存冷冻介质,以及相关...
Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener BioLife Solutions (BLFS) In a report released today, Paul Knight from KeyBanc maintained a Buy rating on BioLife Solutions, with a price target of $30.00. The company’s shares closed last ...
/PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of a portfolio of class-defining...
--BioLife Solutions, Inc., a leading developer and supplier of class-defining bioproduction products and services for the cell and gene therapies and the broader biopharma markets, today announced financial results for the three and six months ended June